Inactivated viral vaccines
This page catalogs 4 standalone hepatitis A vaccine products. Hepatitis A vaccines use inactivated viral technology and are recommended for all children at age 1 year, travelers to endemic areas, and other at-risk groups.
Note: A combination hepatitis A/B vaccine (Twinrix) is also available. See the Combination Vaccines catalog.
Last updated: April 2026.
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Havrix | Hepatitis A vaccine, inactivated | GSK | Inactivated viral | FDA Licensed, 1995 | Pediatric and adult formulations |
| Vaqta | Hepatitis A vaccine, inactivated | Merck | Inactivated viral | FDA Licensed, 1996 | Pediatric and adult formulations |
| Avaxim | Hepatitis A vaccine, inactivated | Sanofi Pasteur | Inactivated viral | Licensed (non-US) | Sanofi product; not US-licensed |
| Epaxal | Hepatitis A vaccine, virosomal | Crucell/Janssen | Virosomal | Licensed (non-US); Discontinued | Virosomal formulation; discontinued |
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026) and EMA Medicines database. Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.